ECM Journal European Cells & Materials Journal Founded by Scientists for Scientists
.

 Home

 

 ECM Journal

 ECM Conferences

 Journal Issues

 

 ECM Issues

 ECM Supplements

 About the Journal

 

 Scope

 Submission

 Editors

 Societies & Sponsors

 Contact

 Related Information

 

 Meetings

 Links

 Paper notification

 

  (Info)

 Site search

 
 


2006   Volume No 11– pages 1-7

Title:The involvement of aggrecan polymorphism in degeneration of human intervertebral disc and articular cartilage

Authors: P Roughley, D Martens, J Rantakokko, M Alini, F Mwale, J Antoniou

Address: Genetics Unit, Shriners Hospital for Children and Department of Surgery, McGill University, Montreal, Quebec, Canada

E-mail: proughley@shriners.mcgill.ca

Key Words: Aggrecan, Polymorphism, Intervertebral disc, Disc degeneration, Articular cartilage, Osteoarthritis.

Publication date: January 18th 2006

Abstract: The functions of the intervertebral disc and of articular cartilage are intimately related to their aggrecan content. Aggrecan is a proteoglycan that interacts with hyaluronan to form large aggregates, which are responsible for the ability of the tissues to resist compressive loads. This function is related to the structure of aggrecan, and in particular to the large number of chondroitin sulphate chains present on its core protein. The chondroitin sulphate chains are present in two adjacent regions of the aggrecan core protein, termed the CS1 and CS2 domains. In the human, the region of the aggrecan gene encoding the CS1 domain exhibits size polymorphism, which can result in variation in the degree of chondroitin sulphate substitution of aggrecan in different individuals. This raises the possibility that the functional properties of aggrecan may vary between individuals, and that those individuals with an inferior aggrecan structure may be more susceptible to premature intervertebral disc or articular cartilage degeneration. Several studies have been performed to demonstrate such an association, but the results have been ambiguous. This review explains the relationship between aggrecan structure and function, describes the technique used to assess aggrecan polymorphism and the conclusions and limitations of the data obtained to date, and discusses the implications for tissue degeneration and clinical practice.

 

Article download: Pages 1-7 (PDF file)

Acrobat Reader:
 

To read this article you will need to install Adobe Acrobat Reader on your computer. Should you experience any difficulty in reading the PDF file we suggest that you save the file to your computer BEFORE opening it from Adobe Acrobat.

     
 

Last modified by Webmaster, March 27, 2007

AO Foundation

 AO Foundation